AT366026B - Verfahren zur herstellung von neuen peptiden - Google Patents

Verfahren zur herstellung von neuen peptiden

Info

Publication number
AT366026B
AT366026B AT0213878A AT213878A AT366026B AT 366026 B AT366026 B AT 366026B AT 0213878 A AT0213878 A AT 0213878A AT 213878 A AT213878 A AT 213878A AT 366026 B AT366026 B AT 366026B
Authority
AT
Austria
Prior art keywords
producing new
new peptides
peptides
producing
new
Prior art date
Application number
AT0213878A
Other languages
German (de)
English (en)
Other versions
ATA213878A (de
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of ATA213878A publication Critical patent/ATA213878A/de
Application granted granted Critical
Publication of AT366026B publication Critical patent/AT366026B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0213878A 1977-03-28 1978-03-24 Verfahren zur herstellung von neuen peptiden AT366026B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/781,580 US4105603A (en) 1977-03-28 1977-03-28 Peptides which effect release of hormones

Publications (2)

Publication Number Publication Date
ATA213878A ATA213878A (de) 1981-07-15
AT366026B true AT366026B (de) 1982-03-10

Family

ID=25123228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0213878A AT366026B (de) 1977-03-28 1978-03-24 Verfahren zur herstellung von neuen peptiden

Country Status (19)

Country Link
US (1) US4105603A (cg-RX-API-DMAC10.html)
JP (1) JPS53130687A (cg-RX-API-DMAC10.html)
AT (1) AT366026B (cg-RX-API-DMAC10.html)
AU (1) AU519122B2 (cg-RX-API-DMAC10.html)
BE (1) BE865380A (cg-RX-API-DMAC10.html)
CA (1) CA1102314A (cg-RX-API-DMAC10.html)
CH (1) CH639361A5 (cg-RX-API-DMAC10.html)
DE (1) DE2813327A1 (cg-RX-API-DMAC10.html)
DK (1) DK131878A (cg-RX-API-DMAC10.html)
ES (1) ES468241A1 (cg-RX-API-DMAC10.html)
FI (1) FI780907A7 (cg-RX-API-DMAC10.html)
FR (1) FR2385688A1 (cg-RX-API-DMAC10.html)
GB (1) GB1564191A (cg-RX-API-DMAC10.html)
IE (1) IE46862B1 (cg-RX-API-DMAC10.html)
IT (1) IT1105152B (cg-RX-API-DMAC10.html)
LU (1) LU79320A1 (cg-RX-API-DMAC10.html)
NL (1) NL7803289A (cg-RX-API-DMAC10.html)
SE (1) SE446190B (cg-RX-API-DMAC10.html)
ZA (1) ZA781599B (cg-RX-API-DMAC10.html)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
US4185010A (en) * 1978-12-12 1980-01-22 American Home Products Corporation Nonapeptides
US4225472A (en) * 1979-05-29 1980-09-30 American Home Products Corporation Truncated somatostatin analogs
USRE30548E (en) * 1979-08-31 1981-03-17 The Salk Institute For Biological Studies Peptides which effect release of hormones
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
FR2523125A1 (fr) * 1982-03-08 1983-09-16 Sanofi Sa Analogues de la somatostatine a activite biologique modifiee et medicaments en contenant
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US4880777A (en) * 1987-09-01 1989-11-14 Eastman Kodak Company Synthetic peptides having growth hormone releasing activity
AU637316B2 (en) * 1988-01-28 1993-05-27 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US6737408B1 (en) 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
CA2380633A1 (en) * 1999-08-06 2001-02-15 Genentech, Inc. Peptide antagonists of factor viia
US20040001827A1 (en) * 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US20060228364A1 (en) * 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
DE60041564D1 (de) 1999-12-24 2009-03-26 Genentech Inc Verfahren und Zusammensetzungen zur Verlängerung der Entsorgungshalbwertszeit von biowirksamen Verbindungen
EP1757311B1 (en) 1999-12-24 2009-02-11 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
CA2539322C (en) * 2003-09-18 2016-07-12 Raven Biotechnologies, Inc. Kid3 and kid3 antibodies that bind thereto
JP4390568B2 (ja) * 2004-01-19 2009-12-24 富士通株式会社 遅延測定システム
EP1765868B1 (en) * 2004-06-07 2016-04-20 MacroGenics, Inc. Transferrin receptor antibodies
CA2583137A1 (en) * 2004-10-05 2006-04-20 Genentech, Inc. Therapeutic agents with decreased toxicity
CA2593786A1 (en) 2005-01-12 2006-07-20 Raven Biotechnologies, Inc. Kid31 and antibodies that bind thereto
WO2006083852A2 (en) * 2005-01-31 2006-08-10 Raven Biotechnologies, Inc. Luca2 and antibodies that bind thereto
WO2006084078A2 (en) * 2005-02-02 2006-08-10 Raven Biotechnologies, Inc. Jam-3 and antibodies that bind thereto
MX2007009222A (es) * 2005-02-02 2008-01-16 Raven Biotechnologies Inc Moduladores de adam-9.
CA2597171A1 (en) * 2005-02-03 2006-08-10 Raven Biotechnologies, Inc. Antibodies to oncostatin m receptor
US20070197445A1 (en) 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite
JP5601836B2 (ja) * 2006-11-08 2014-10-08 マクロジェニックス ウエスト， インコーポレイテッド Ｔｅｓ７およびｔｅｓ７に結合する抗体
US20110014287A1 (en) 2009-04-20 2011-01-20 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
HUE045487T2 (hu) 2010-03-04 2019-12-30 Macrogenics Inc B7-H3-ra reaktív antitestek, immunológiailag aktív fragmenseik és alkalmazásaik
PH12012501751A1 (en) 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
SG10201509588TA (en) 2011-05-21 2015-12-30 Macrogenics Inc CD3-Binding Molecules Capable Of Binding To Human And Non-Human CD3
SG11201400073SA (en) 2011-08-23 2014-03-28 Harvard College Peptide nanoparticles and uses thereof
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
PT2968520T (pt) 2013-03-14 2021-08-19 Macrogenics Inc Moléculas biespecíficas que são imunorreativas com células efetoras imunitárias que expressam um recetor de ativação
US20160106813A1 (en) 2013-03-29 2016-04-21 Centre National De La Recherche Schientifique (Cnrs) Cgrp receptor agonist for hiv treatment or prevention
SG11201609912TA (en) 2014-05-29 2016-12-29 Macrogenics Inc Tri-specific binding molecules that specifically bind to multiple cancer antigens and methods of use thereof
AU2015323860B2 (en) 2014-09-29 2021-05-27 Duke University Bispecific molecules comprising an HIV-1 envelope targeting arm
WO2016122702A1 (en) 2015-01-26 2016-08-04 Macrogenics, Inc. Multivalent molecules comprising dr5-binding domains
TWI773646B (zh) 2015-06-08 2022-08-11 美商宏觀基因股份有限公司 結合lag-3的分子和其使用方法
PT3456346T (pt) 2015-07-30 2021-09-28 Macrogenics Inc Moléculas de ligação pd-1 e lag-3 e respetivos métodos de utilização
RU2731202C2 (ru) 2015-10-08 2020-08-31 Макродженикс, Инк. Комбинированная терапия для лечения рака
CN108925136B (zh) 2015-12-02 2022-02-01 斯特赛恩斯公司 特异于糖基化的btla（b和t淋巴细胞衰减因子）的抗体
UA125611C2 (uk) 2015-12-14 2022-05-04 Макродженікс, Інк. Біспецифічні молекули, що мають імунореактивність відносно pd-1 і ctla-4, і способи їх застосування
JP7002467B2 (ja) 2016-04-15 2022-01-20 マクロジェニクス，インコーポレーテッド 新規のｂ７‐ｈ３結合分子、その抗体薬物コンジュゲート、及びその使用方法
US10111929B1 (en) 2017-04-07 2018-10-30 Ez Ip, Llc Growth hormone releasing factor analogs and uses
CN114729045B (zh) 2019-09-26 2025-09-09 斯特库比公司 对糖基化的ctla-4特异性的抗体及其使用方法
EP4041768A1 (en) 2019-10-09 2022-08-17 StCube & Co. Antibodies specific to glycosylated lag3 and methods of use thereof
US11596665B2 (en) 2020-06-23 2023-03-07 Chanda Zaveri Skin lightening formulations
US11951203B2 (en) 2020-08-26 2024-04-09 Chanda Zaveri Deep wrinkle vanishing compositions
US11793746B2 (en) 2020-10-01 2023-10-24 Chanda Zaveri Intense skin hydration systems and methods
US20220110852A1 (en) 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
US3917578A (en) * 1973-12-10 1975-11-04 Ayerst Mckenna & Harrison Process for producing somatostatin and intermediates
US3882098A (en) * 1974-01-03 1975-05-06 American Home Prod Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates
US4011207A (en) * 1974-12-27 1977-03-08 American Home Products Corporation Des-(Ala1, Gly2,Lys4 -Srif, Des-(Ala1, Gly2, Lys4)-D-Trp8 -Srif and intermediates
US3933784A (en) * 1975-01-27 1976-01-20 American Home Products Corporation Des-(ser13)-srif and intermediates

Also Published As

Publication number Publication date
CH639361A5 (de) 1983-11-15
BE865380A (fr) 1978-07-17
US4105603A (en) 1978-08-08
GB1564191A (en) 1980-04-02
IE780511L (en) 1978-09-28
FI780907A7 (fi) 1978-09-29
DE2813327C2 (cg-RX-API-DMAC10.html) 1988-08-18
ZA781599B (en) 1979-10-31
IT7848586A0 (it) 1978-03-23
IE46862B1 (en) 1983-10-19
IT1105152B (it) 1985-10-28
SE446190B (sv) 1986-08-18
JPS6141920B2 (cg-RX-API-DMAC10.html) 1986-09-18
AU519122B2 (en) 1981-11-12
NL7803289A (nl) 1978-10-02
CA1102314A (en) 1981-06-02
FR2385688A1 (fr) 1978-10-27
ES468241A1 (es) 1978-12-01
DE2813327A1 (de) 1978-10-05
AU3430778A (en) 1979-09-27
JPS53130687A (en) 1978-11-14
DK131878A (da) 1978-09-29
LU79320A1 (fr) 1978-06-29
SE7803318L (sv) 1978-09-29
ATA213878A (de) 1981-07-15
FR2385688B1 (cg-RX-API-DMAC10.html) 1983-10-07

Similar Documents

Publication Publication Date Title
AT366026B (de) Verfahren zur herstellung von neuen peptiden
AT353992B (de) Verfahren zur herstellung von neuen peptiden
AT360674B (de) Verfahren zur herstellung von neuen peptiden
AT382625B (de) Verfahren zur herstellung von neuen peptiden
AT372093B (de) Verfahren zur herstellung von neuen corticoid-17- alkylcarbonaten
AT360153B (de) Verfahren zur herstellung von neuen ver- bindungen
AT370090B (de) Verfahren zur herstellung von neuen cyclopeptiden
AT359219B (de) Verfahren zur herstellung von neuen peptiden
LU79212A1 (de) Verfahren zur herstellung von neuen 4-acylamino-phenylaethanolaminen
AT363198B (de) Verfahren zur herstellung von neuen peptidverbindungen
AT371455B (de) Verfahren zur herstellung von neuen prostanderivaten
AT357262B (de) Verfahren zur herstellung von neuen antibiotika
AT368753B (de) Verfahren zur herstellung von neuen azacycloalkanen
AT359660B (de) Verfahren zur herstellung von neuen polypeptiden
AT368137B (de) Verfahren zur herstellung von neuen 4-amino-5alkylthiopyrimidinen
AT366368B (de) Verfahren zur herstellung von neuen chinolylguanidinen
AT361622B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosid-anitbiotika
AT358169B (de) Verfahren zur herstellung von neuen ver- bindungen
AT372690B (de) Verfahren zur herstellung von neuen polyhydantoinen
AT360676B (de) Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen
ATA750578A (de) Verfahren zur herstellung von neuen pyridothiazo- linen
AT364081B (de) Verfahren zur herstellung von neuen antibiotika
AT359517B (de) Verfahren zur herstellung von neuen alfa- -halogenaethylcarbamidsaeurehalogeniden
ATA68579A (de) Verfahren zur herstellung von neuen peptiden
ATA391780A (de) Verfahren zur herstellung von neuen aryltrifluor- aethanolen

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELJ Ceased due to non-payment of the annual fee